$678 Million Healthcare Settlement Reached with Novartis
Novartis, a pharmaceutical company, agreed to a $678 million healthcare settlement with the Department of Justice (DOJ). Novartis was accused of violating the Anti-Kickback Statute (AKS) and False Claims Act (FCA) by having healthcare providers attend and speak at events to entice providers to prescribe Novartis to their patients. The details of the healthcare settlement are discussed below. What Did Novartis Do [...]